Clinical characteristics of patients with lower-limb PTS (n = 10)
| Variable . | Value∗ . |
|---|---|
| Location of index lower-limb DVT | |
| Ilio-femoral | 6 (60%) |
| Femoro-popliteal | 3 (30%) |
| Infrapopliteal | 1 (10%) |
| Age at diagnosis of DVT in y | 13 (12-15) |
| Age at study participation in y | 17 (15-18) |
| Time since DVT diagnosis in y | 3 (1.6-10.5) |
| DVT risk factors† | |
| Antiphospholipid syndrome | 3 (30%) |
| May-Thurner syndrome | 3 (30%) |
| Central venous catheter | 2 (20%) |
| Oral contraceptives | 1 (10%) |
| Management strategy | |
| Anticoagulation alone | 9 (90%) |
| Thrombolysis/thrombectomy | 1 (10%) |
| Anticoagulation length in mo | 18 (5-53) |
| Variable . | Value∗ . |
|---|---|
| Location of index lower-limb DVT | |
| Ilio-femoral | 6 (60%) |
| Femoro-popliteal | 3 (30%) |
| Infrapopliteal | 1 (10%) |
| Age at diagnosis of DVT in y | 13 (12-15) |
| Age at study participation in y | 17 (15-18) |
| Time since DVT diagnosis in y | 3 (1.6-10.5) |
| DVT risk factors† | |
| Antiphospholipid syndrome | 3 (30%) |
| May-Thurner syndrome | 3 (30%) |
| Central venous catheter | 2 (20%) |
| Oral contraceptives | 1 (10%) |
| Management strategy | |
| Anticoagulation alone | 9 (90%) |
| Thrombolysis/thrombectomy | 1 (10%) |
| Anticoagulation length in mo | 18 (5-53) |